Real Talk on GLP-1s: From Chronic Obesity Patient to Registered Dietitian | Guest: Summer Kessel, RD

Epi 211 In this powerful episode of Our Sleeved Life Podcast, Kellie and Mel continue the conversation around GLP-1 medications for weight loss by speaking with Summer Kessel, RD, LDN, CSO—a registered dietitian and former chronic obesity patient who lost 140+ pounds with the help of GLP-1 therapy.🎙️ Summer shares her deeply personal journey of weight gain, emotional eating, obesity stigma in healthcare, and what finally led her to try GLP-1 medication. Her story comes full circle as she becomes a Sequence member, sees success, and eventually joins the company as a bariatric and clinical dietitian.💉 GLP-1 Medications ExplainedHow they work, who they're for, and how Summer used them to manage chronic obesity and maintain long-term results.🧠 Bias in Medical SettingsSummer discusses the weight stigma she faced as a patient—and later as a healthcare provider—and why the system needs change.🏥 Sequence: From Patient to ProLearn how Sequence supports patients on GLP-1 therapy, and why Summer now helps others walk the same path she did.👩‍🍳 Nutrition Advice from a GLP-1 DietitianGet tips on eating patterns, sustainable habits, and what to focus on while taking medication.🎧 This is a must-listen for anyone considering GLP-1 meds, working with a dietitian, or struggling with weight regain after bariatric surgery.🔔 Subscribe for more honest stories, expert discussions, and actionable tools for your bariatric and weight loss journey.📲 Connect & Learn More:Follow Summer: @summerthedietitian on InstagramSequence Website: JoinSequence.comFollow Sequence on InstagramMedical Director Dr. Spencer Nadolsky: @drnadolsky on Instagram🛍️ OSLP-Recommended Bariatric Essentials:ProCare Health – Code: OSLPBariLifeThe Sleeved DietitianUBA Home – Code: OSLPSABP Weight LossAnd more via OSLP Amazon Storefront Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.